[1] Tsukui T, Hildesheim A, Schiffman MH, et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.Cancer Res, 1996, 56:3967-3974. [2] Loetseher P, Ugueeioni M, Bordoli L, et al. CCR5 is characteristic of Th1 lymphoeytes. Nature, 1998, 391:344-345. [3] Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest, 1998, 101:746-754. [4] Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science, 1997,277:2005-2007. [5] Gerber BO, Zanni MP, Uguccioni M, et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol, 1997, 7:836-843. [6] 李振,曾耀英,何贤辉,等.正常成人外周血Th1/Th2细胞亚群体外活化的研究.中国病理生理学杂志,2001,17:302-304. [7] Malejczyk J, Majewski S, Jablonska S. Cellular immunity in cutaneous and genital HPV infections. Clin Dermatol, 1997, 15:261-274. [8] Hahn S, Stalder T, Wernli M, et al. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fasligand interaction. Eur J Immunol, 1995, 25:2679-2685. |